⌘K

Login Start Free

Home/Filings/4/0000897069-25-000787

4//SEC Filing

Young David 4

Accession 0000897069-25-000787

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 5:16 PM ET

Size

8.0 KB

Accession

0000897069-25-000787

Insider Transaction Report

Form 4

Period: 2025-04-01

Processa Pharmaceuticals, Inc.PCSA

DirectorPres. Research & Development

Transactions

Tax Payment
Common Stock
2025-04-01$0.41/sh−5,345$2,202→ 217,332 total
Exercise/Conversion
Common Stock
2025-04-01+17,272→ 222,677 total

Holdings

Common Stock
(indirect: By Trust)
30,985
Common Stock
(indirect: By Family Entities)
10,786
Common Stock
(indirect: By LLC)
18,544

Footnotes (1)

[F1]Distribution of vested restricted shares.

Documents

1 file

4
form4.xmlPrimary

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001378166

Filing Metadata

Form type: 4
Filed: Apr 10, 8:00 PM ET
Accepted: Apr 11, 5:16 PM ET
Size: 8.0 KB

View on SEC.gov